After controlling for age, gender and TNM stage, the TTN/OBSCN mutant phenotypes remained statistically significance (P < .05), which suggested that the TTN/OBSCN mutant phenotypes was also an independent protective factor of OS in CRC (Figure S1). This evidence concerns the gene TTN and colorectal carcinoma.